Dilip Shanghvi
- All
- News
- Videos
- Web Stories
-
Top 10 Richest Indians On Forbes 2024 List
Forbes has recently revealed its annual ranking of the richest Indians in 2024.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
IIT Bombay Awards Degrees To 168 Students At Interim Session Of Convocation
The function was presided by Dilip Shanghvi, Chairman of the Board of Governors, IIT Bombay and Prof. Devang V. Khakhar, Director, IIT Bombay among others.
-
Sun Pharma Shares Plunge 13% On Weak Forecast. Should You Buy?
Sun Pharma has been working on fixing problems at its Halol plant in India, where the US Food and Drug Administration has raised concerns about quality control violations.
-
Notes Ban Hits Super Rich, 11 Lose Billionaire Status: Report
The country now has 132 billionaires with a net worth of $1 billion or more and the cumulative wealth of the ultra-rich people stood at $392 billion, according to Hurun Global Rich List India.
-
Mukesh Ambani's Wealth At $22.7 Billion Equals This Nation's GDP: Forbes
According to Forbes, the total wealth of India's top five billionaires, which stands at a whopping $83.7 billion, is more than the cost of 1,230 Mars Orbiter 'Mangalyaan' Missions and is more than 18 times the cost of hosting the 2016 Rio Olympics.
-
Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test
Both Shanghvi's eye for value and his tenaciousness were exemplified in the 2010 takeover of Israel-based Taro Pharmaceutical Industries Ltd.
-
Gujaratis Dominate Forbes India Rich List
Gujaratis seem to be among the most dominant communities when it comes to wealth creation, with Ambanis, Adanis, Shanghvis and Patels cornering a large number of top positions on the list of India's richest 100 released by Forbes on Thursday.
-
Mukesh Ambani Tops Forbes Richest Indians List For Ninth Year In A Row
Industrialist Mukesh Ambani was named India's richest person for a ninth year in a row with a sharp increase in networth to $22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion.
-
Making Ranbaxy Units Compliant Time Consuming: Sun Pharma
Sun Pharma sees the remediation process at erstwhile Ranbaxy facilities as a "time consuming" process even as it aims to bring at least one of the plants to conform to current good manufacturing practice regulations (cGMP) in the current fiscal year.
-
Not Perturbed Over Withdrawal Of Payments Bank Licences: Rajan
RBI Governor Raghuram Rajan on Tuesday said he is not "overly perturbed" by surrender of Payments Bank licences by some companies but indicated that there could be a mechanism to ensure that entities apply for licences after due diligence as there is a cost involved in vetting them.
-
Dilip Shanghvi Drops Plans To Form Payments Bank With IDFC, Telenor
India's second richest man, Dilip Shanghvi, said on Friday he had shelved plans to form a payments bank jointly with the Indian financial firm IDFC Bank and an arm of Norway's Telenor, but did not disclose the reason.
-
Sun Pharma Acquires 14 Brands From Novartis for Rs 1,940 Crore
Drug major Sun Pharma has forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
-
Telenor Looking to Start Payment Bank in India This Year
Telenor, along with Dilip Shanghvi of Sun Pharmaceuticals and IDFC, had earlier received RBI's approval to set up the payment bank.
-
Mukesh Ambani Remains Richest Indian, Net Worth Jumps 30%: Report
Industrialist Mukesh Ambani remains India's richest person with a sharp surge of 30 per cent in his net worth to $26 billion (Rs 1.78 lakh crore at $1 = Rs 68.56), pushing his global rank to 21st on a worldwide rich list topped by Bill Gates.
-
Top 10 Richest Indians On Forbes 2024 List
Forbes has recently revealed its annual ranking of the richest Indians in 2024.
-
Sun Pharma Records Rs 2,277 Crore March Quarter Net Loss
Sun Pharmaceutical Industries on Monday said its consolidated net loss stood at Rs 2,277 crore for the fourth quarter ended March 2022
-
IIT Bombay Awards Degrees To 168 Students At Interim Session Of Convocation
The function was presided by Dilip Shanghvi, Chairman of the Board of Governors, IIT Bombay and Prof. Devang V. Khakhar, Director, IIT Bombay among others.
-
Sun Pharma Shares Plunge 13% On Weak Forecast. Should You Buy?
Sun Pharma has been working on fixing problems at its Halol plant in India, where the US Food and Drug Administration has raised concerns about quality control violations.
-
Notes Ban Hits Super Rich, 11 Lose Billionaire Status: Report
The country now has 132 billionaires with a net worth of $1 billion or more and the cumulative wealth of the ultra-rich people stood at $392 billion, according to Hurun Global Rich List India.
-
Mukesh Ambani's Wealth At $22.7 Billion Equals This Nation's GDP: Forbes
According to Forbes, the total wealth of India's top five billionaires, which stands at a whopping $83.7 billion, is more than the cost of 1,230 Mars Orbiter 'Mangalyaan' Missions and is more than 18 times the cost of hosting the 2016 Rio Olympics.
-
Dilip Shanghvi, Man Behind India's Best Stock, Now Faces His Greatest Test
Both Shanghvi's eye for value and his tenaciousness were exemplified in the 2010 takeover of Israel-based Taro Pharmaceutical Industries Ltd.
-
Gujaratis Dominate Forbes India Rich List
Gujaratis seem to be among the most dominant communities when it comes to wealth creation, with Ambanis, Adanis, Shanghvis and Patels cornering a large number of top positions on the list of India's richest 100 released by Forbes on Thursday.
-
Mukesh Ambani Tops Forbes Richest Indians List For Ninth Year In A Row
Industrialist Mukesh Ambani was named India's richest person for a ninth year in a row with a sharp increase in networth to $22.7 billion, while Sun Pharma's Dilip Shanghvi was ranked a distant second with a wealth of $16.9 billion.
-
Making Ranbaxy Units Compliant Time Consuming: Sun Pharma
Sun Pharma sees the remediation process at erstwhile Ranbaxy facilities as a "time consuming" process even as it aims to bring at least one of the plants to conform to current good manufacturing practice regulations (cGMP) in the current fiscal year.
-
Not Perturbed Over Withdrawal Of Payments Bank Licences: Rajan
RBI Governor Raghuram Rajan on Tuesday said he is not "overly perturbed" by surrender of Payments Bank licences by some companies but indicated that there could be a mechanism to ensure that entities apply for licences after due diligence as there is a cost involved in vetting them.
-
Dilip Shanghvi Drops Plans To Form Payments Bank With IDFC, Telenor
India's second richest man, Dilip Shanghvi, said on Friday he had shelved plans to form a payments bank jointly with the Indian financial firm IDFC Bank and an arm of Norway's Telenor, but did not disclose the reason.
-
Sun Pharma Acquires 14 Brands From Novartis for Rs 1,940 Crore
Drug major Sun Pharma has forayed into the Japanese prescription market by acquiring 14 brands from Swiss drug firm Novartis for $293 million (over Rs 1,940 crore).
-
Telenor Looking to Start Payment Bank in India This Year
Telenor, along with Dilip Shanghvi of Sun Pharmaceuticals and IDFC, had earlier received RBI's approval to set up the payment bank.
-
Mukesh Ambani Remains Richest Indian, Net Worth Jumps 30%: Report
Industrialist Mukesh Ambani remains India's richest person with a sharp surge of 30 per cent in his net worth to $26 billion (Rs 1.78 lakh crore at $1 = Rs 68.56), pushing his global rank to 21st on a worldwide rich list topped by Bill Gates.
